In Case 30, which had primary OMM and lung metastasis with no therapeutic intervention, treatment with anti-PD-1 antibody yielded complete tumor regression of the target lesion (oral mass) and rapid resolution of symptoms such as bleeding from the tumor until day 67 (Fig. 4B). This evidence concerns the gene PDCD1 and neoplasm.